Technical Analysis for PROG - Progenity, Inc.

Grade Last Price % Change Price Change
D 6.2 -0.32% -0.02
PROG closed down 0.32 percent on Friday, January 22, 2021, on 44 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Up
Historical PROG trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
MACD Bullish Signal Line Cross Bullish -0.32%
NR7 Range Contraction -0.32%
Wide Bands Range Expansion -0.32%
Wide Bands Range Expansion 1.47%
Crossed Above 20 DMA Bullish -1.90%
Pocket Pivot Bullish Swing Setup -1.90%
Older End-of-Day Signals for PROG ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 17 hours ago
Fell Below 10 DMA about 17 hours ago
Fell Below Previous Day's Low about 18 hours ago
60 Minute Opening Range Breakout about 19 hours ago
10 DMA Support about 20 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Progenity, Inc. Description

Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine. Progenity provides in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages. The company applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Disease Drug Delivery In Vitro Genomics Precision Medicine Systems Biology Proteomics Systems Science

Is PROG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.92
52 Week Low 3.08
Average Volume 980,936
200-Day Moving Average 0.00
50-Day Moving Average 4.91
20-Day Moving Average 5.84
10-Day Moving Average 6.00
Average True Range 0.64
ADX 26.82
+DI 27.75
-DI 17.04
Chandelier Exit (Long, 3 ATRs ) 5.63
Chandelier Exit (Short, 3 ATRs ) 6.59
Upper Bollinger Band 6.77
Lower Bollinger Band 4.90
Percent B (%b) 0.69
BandWidth 32.09
MACD Line 0.27
MACD Signal Line 0.26
MACD Histogram 0.0037
Fundamentals Value
Market Cap 291.25 Million
Num Shares 47 Million
EPS -0.99
Price-to-Earnings (P/E) Ratio -6.27
Price-to-Sales 1.91
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.67
Resistance 3 (R3) 6.63 6.45 6.59
Resistance 2 (R2) 6.45 6.33 6.46 6.56
Resistance 1 (R1) 6.32 6.26 6.39 6.36 6.54
Pivot Point 6.14 6.14 6.17 6.15 6.14
Support 1 (S1) 6.01 6.02 6.08 6.05 5.86
Support 2 (S2) 5.83 5.95 5.84 5.84
Support 3 (S3) 5.70 5.83 5.81
Support 4 (S4) 5.74